Antileukocyte adhesion therapy: preclinical trials and combination therapy

被引：26

作者：

Clark, WM ^{[1
]}

Zivin, JA ^{[1
]}

机构：

[1] UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093

来源：

NEUROLOGY | 1997年 / 49卷 / 05期

关键词：

D O I：

10.1212/WNL.49.5_Suppl_4.S32

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S32 / S38

页数：7

共 45 条

[1]

ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175

[2]

ARFORS KE, 1987, BLOOD, V69, P338

[3] MONOCLONAL-ANTIBODIES TO THE LEUKOCYTE MEMBRANE CD18 GLYCOPROTEIN COMPLEX AND TO INTERCELLULAR-ADHESION MOLECULE-1 INHIBIT LEUKOCYTE-ENDOTHELIAL ADHESION IN RABBITS [J].

ARGENBRIGHT, LW ;

LETTS, LG ;

ROTHLEIN, R .

JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 49 (03) :253-257

[4]

BARTON R, 1989, J IMMUNOL, V142, P1278

[5] THE ROLE OF NEUTROPHILS AND PLATELETS IN A RABBIT MODEL OF THROMBOEMBOLIC STROKE [J].

BEDNAR, MM ;

RAYMOND, S ;

MCAULIFFE, T ;

LODGE, PA ;

GROSS, CE .

STROKE, 1991, 22 (01) :44-50

[6] MONOCLONAL-ANTIBODY TO THE ICAM-1 ADHESION SITE REDUCES NEUROLOGICAL DAMAGE IN A RABBIT CEREBRAL EMBOLISM STROKE MODEL [J].

BOWES, MP ;

ZIVIN, JA ;

ROTHLEIN, R .

EXPERIMENTAL NEUROLOGY, 1993, 119 (02) :215-219

[7] MONOCLONAL-ANTIBODIES PREVENTING LEUKOCYTE ACTIVATION REDUCE EXPERIMENTAL NEUROLOGIC INJURY AND ENHANCE EFFICACY OF THROMBOLYTIC THERAPY [J].

BOWES, MP ;

ROTHLEIN, R ;

FAGAN, SC ;

ZIVIN, JA .

NEUROLOGY, 1995, 45 (04) :815-819

[8] ANTI-CD11B MONOCLONAL-ANTIBODY REDUCES ISCHEMIC CELL-DAMAGE AFTER TRANSIENT FOCAL CEREBRAL-ISCHEMIA IN RAT [J].

CHEN, H ;

CHOPP, M ;

ZHANG, RL ;

BODZIN, G ;

CHEN, Q ;

RUSCHE, JR ;

TODD, RF .

ANNALS OF NEUROLOGY, 1994, 35 (04) :458-463

[9] POSTISCHEMIC ADMINISTRATION OF AN ANTI-MAC-1 ANTIBODY REDUCES ISCHEMIC CELL-DAMAGE AFTER TRANSIENT MIDDLE CEREBRAL-ARTERY OCCLUSION IN RATS [J].

CHOPP, M ;

ZHANG, RL ;

CHEN, H ;

LI, Y ;

JIANG, N ;

RUSCHE, JR .

STROKE, 1994, 25 (04) :869-875

[10]

Clark W M, 1992, J Stroke Cerebrovasc Dis, V2, P80, DOI 10.1016/S1052-3057(10)80210-1

← 1 2 3 4 5 →